Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome‐Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case‐Control Study

24 Jan 2017

Abstract excerpt

BACKGROUND: Global measures of peripheral blood DNA methylation have been associated with risk of some malignancies, including breast, bladder, and gastric cancer. Here, we examined genome-wide measures of peripheral blood DNA methylation in prostate cancer and its non-aggressive and aggressive disease forms. METHODS: We used a matched, case-control study of 687 incident prostate cancer samples, nested within a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28116812
DOI: 10.1002/pros.23289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome‐Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case‐Control StudyPMID 28116812Read ↗

Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk.Semantic proximity Read ↗

Integrating Multi-Omics Data to Uncover Prostate Tissue DNA Methylation Biomarkers and Target Genes for Prostate Cancer Risk.Semantic proximity Read ↗

Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.Semantic proximity Read ↗

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.Semantic proximity Read ↗

Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate CancerSemantic proximity Read ↗

Genome-Wide Methylation Analysis of Prostate Tissues Reveals Global Methylation Patterns of Prostate CancerSemantic proximity Read ↗

DNA methylation changes in prostate cancer: current developments and future clinical implementationSemantic proximity Read ↗

Heritable methylation marks associated with breast and prostate cancer risk.Semantic proximity Read ↗

DNA methylation signatures of Prostate Cancer in peripheral T-cellsSemantic proximity Read ↗

The Landscape of Prostate Tumour MethylationSemantic proximity Read ↗

Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate CancerSemantic proximity Read ↗

Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.